General Biologicals Corporation

TWO:4117 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$9.20 Million

NT$304.54 Million TWD

Market Cap Rank

#31593 Global

#1866 in Taiwan

Share Price

NT$4.30

Change (1 day)

+3.61%

52-Week Range

NT$4.15 - NT$13.80

All Time High

NT$13.80

General Biologicals Corporation - Asset Resilience Ratio

Latest as of June 2023: 1.70%

General Biologicals Corporation (4117) has an Asset Resilience Ratio of 1.70% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$31.40 Million

Cash + Short-term Investments

Total Assets

NT$1.85 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2022)

This chart shows how General Biologicals Corporation's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down General Biologicals Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$31.40 Million	1.7%
Total Liquid Assets	NT$31.40 Million	1.70%

Asset Resilience Insights

Limited Liquidity: General Biologicals Corporation maintains only 1.70% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.